User Guidelines:

Procedure for requesting a PML screen.

1. Provide evidence that the targeted gene encodes a chloroplast-localized protein or that disrupting the gene will cause a phenotype represented in the PML collection

To avoid wasting time and resources, we will screen our collection only if there is good evidence that the targeted gene encodes a chloroplast-localized protein. Any one of the following types of evidence is sufficient:

a) Predicted chloroplast targeting sequence

If the N-terminal sequence of the gene product is available, it should be run through two prediction programs: TargetP (http://www.cbs.dtu.dk/services/TargetP/) and Predotar (http://www.inra.fr/Internet/Produits/Predotar/)

If both algorithms predict a chloroplast-transit peptide, this is sufficient evidence for a screen. If just one algorithm predicts a chloroplast-transit peptide, we would prefer that some other type of evidence for chloroplast-localization is provided in addition.

Caution! The ChloroP and PSort algorithms are less accurate.

Note: A predicted chloroplast targeting sequence on the predicted ortholog from another species (e.g. Arabidopsis) is also sufficient. However, the method by which the orthologous relationship was established must be provided.

b) Cellular fractionation

Demonstrate that the protein of interest is enriched in isolated chloroplasts with respect to its concentration in total leaf extracts. Markers for cytosol, chloroplasts, and mitochondria must be included in the analysis.

The data must be provided, preferably as an email attachment.

c) Chloroplast localization during in vitro import assays or during transient expression of GFP fusion proteins.

If a full-length cDNA is available, one can test whether the protein can be imported into isolated chloroplasts, or whether a C-terminal fusion with GFP targets the protein to chloroplasts following transient expression in cultured cells. The data must be provided, preferably as an email attachment.

d) Mutant Phenotype

if a mutation in this gene has been obtained previously that causes one of the phenotypes represented in our collection (chlorophyll-deficiency or high chlorophyll fluorescence), this is sufficient evidence that an allele should be represented in our collection.

2. Design and test gene-specific primers to be used in the screen.

See the Primer Design page.

3. Provide primers, gene map, gene sequence, and the digoxigenin-labelled probe to the PML technician in the Barkan lab.

Primers: We need 15-20 nmoles of each primer (about 110-150 µg for a 20-mer oligo). Primers can either be lyophilized or diluted in water. (The exact concentration is not critical, as long as it is clearly indicated... anywhere from 50-5000 µM.) Primers can be sent either lyophilized at room temperature or diluted and sent on WET ice via "overnight standard" mail. A copy of the information sheet from the company that synthesized the primers would also be helpful.

Probes: We will need roughly 200ng of each working DIG-labelled probe. The probe can either be lyophilized and sent at room temperature, or frozen in TE or hybridization buffer and sent on WET ice via "overnight standard" mail. Please include information on how the probe was synthesized (template & primers used). The concentration and/or amount of probe should be clearly indicated.

Gene Map: A simple cartoon showing the location of relevant gene features eg; start codon, stop codon and introns. The map should also indicate primer locations, and the span of the DIG-labelled probe to be used for detection of Mu insertions. Ideally we would like this map in electronic form (PICT, JPEG or TIFF are the prefered formats)

Mailing address:

Attn: PML Technician
c/o the Barkan Lab
Institute of Molecular Biology
University of Oregon
Eugene, OR 97403

Home